Non-Traumatic Rhabdomyolysis: The Emerging Role of CYP 3A4 in Diabetes Mellitus

Gangopadhyay K.K. , Ryder R.E. Nontraumatic rhabdomyolysis: an unusual complication of diabetic hyperosmolar nonketotic (HONK) state. J R Soc Med 2006; 99: 200

Law M. , Rudnicka A.R. Statin safety: a systematic review. Am J Cardiol 2006; 97: S52–60

Ricaurte B. , Guirguis A. , Taylor H.C. , Zabriskie D. Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity. Ann Pharmacother 2006; 40: 753–7

Roten L. , Schoenenberger R.A. , Krahenbuhl S. , Schlienger R.G. Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother 2004; 38: 978–81

Movahed M.R. , Hashemzadeh M. , Jamal M.M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315–18